Anderson T, Bender R A, Rosenoff S H, Brereton H D, Chabner B A, DeVita V T, Hubbard S P, Young R C
Cancer Treat Rep. 1977 Sep;61(6):1017-22.
Peritoneoscopy was performed in 22 patients with non-Hodgkin's lymphoma as a re-staging technique to rule out relapse or persistence of active disease after intensive chemotherapy and/or radiotherapy. Fifteen patients with previous hepatic involvement achieved a complete clinical remission; however, five patients (33%) had persistent disease proved by biopsy at peritoneoscopy. In seven patients suspected to have a clinical relapse, peritoneoscopy biopsies documented relapse in three patients (43%), including two patients with negative percutaneous liver biopsies. Because of its low morbidity rate (4%), peritoneoscopy can be utilized to re-stage hepatic involvement by non-Hodgkin's lymphoma patients more accurately than percutaneous liver biopsies and with less morbidity than laparotomy.
对22例非霍奇金淋巴瘤患者进行了腹腔镜检查，作为一种再分期技术，以排除强化化疗和/或放疗后活动性疾病的复发或持续存在。15例既往有肝脏受累的患者实现了临床完全缓解；然而，5例患者（33%）在腹腔镜检查时经活检证实存在持续性疾病。在7例疑似临床复发的患者中，腹腔镜检查活检证实3例患者（43%）复发，其中2例经皮肝活检为阴性。由于其低发病率（4%），腹腔镜检查可用于更准确地对非霍奇金淋巴瘤患者的肝脏受累情况进行再分期，比经皮肝活检更准确，且发病率低于剖腹手术。
